COVID-19 rapid evidence and research guide

The COVID-19 pandemic literature is rapidly expanding and evolving. We have compiled a variety of resources to help our researchers retrieve the latest published information. Please suggest any other relevant resources by sending them to gw2386@cumc.columbia.edu.

 

Sections

Systematic Reviews and Other Evidence Synthesis

Guidance, Guidelines, and Information

Clinical Point-of-Care Tools

Journal, Publisher and Data Resources

Consumer Health Information and Multimedia Resources

Maps and Visuals

 

Systematic Reviews and Other Evidence Synthesis:

Cochrane Library Special Collection assembles Cochrane Reviews relevant to the prevention of infection. It includes reviews that evaluate WHO suggested interventions, as well as reviews from three Cochrane Networks. Many reviews in this collection have associated Cochrane Clinical Answers.

  • Cochrane Library Special Collection: Coronavirus (COVID-19): Evidence Relevant to Critical Care

This Special Collection includes Cochrane Reviews on: fluid and vasopressor therapy; respiratory support and mechanical ventilation; weaning mechanical ventilation; managing hypoxaemia; pharmacological treatment; and nutrition in intensive care. Many of these reviews have associated Cochrane Clinical Answers.

F1000 Faculty have evaluated the COVID-19 literature and handpicked the most relevant and important research. To assist in addressing this pandemic, all of these articles are now freely available to access on F1000Prime.

This website includes links to clinical studies, the latest journal article citations, GenBank sequence data, and many more additional resources related to coronavirus.

LitCovid is a curated literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus. It is the most comprehensive resource on the subject, providing a central access to 1120 (and growing) research articles in PubMed. The articles are updated daily and are further categorized by different research topics and geographic locations for improved access.

 

Guidance, Guidelines, and Information:

 

Clinical Point-of-Care Tools:

 

Journal, Publisher, and Data Resources:

BMJ is offering free online resources to help researchers and healthcare professionals understand and respond to the global health emergency caused by coronavirus.

To support medical researchers and healthcare professionals better understand and combat the disease associated with COVID-19, Clarivate has assembled an array of resources.

Since the novel coronavirus SARS-CoV-2 was first identified in Wuhan, China in late 2019, Columbia University Mailman School of Public Health has been working on multiple fronts to respond to the spread of the virus. Our experts are conducting research that informs the public and policymakers; collaborating with government authorities on pandemic response; advising Columbia University leadership on contingency planning; providing insights to credible news sources; and mobilizing volunteer efforts.

The Offices of the Executive Vice President for Research are continuing to monitor the impact of COVID-19 on research activities. This website is updated daily. Contact COVID19_research@columbia.edu for all research-related questions.

Columbia researchers have mobilized to address all aspects of COVID-19 and the human experience. Researcher contributions reveal the virus' composition and spread, mitigate the potential impact on our social and political institutions, and pioneer clinical trials to test new treatment options.

A free resource of over 29,000 scholarly articles, including over 13,000 with full text, about COVID-19 and the coronavirus family of viruses for use by the global research community.

This map allows you to interactively explore research output related to COVID-19, coronavirus and SARS-CoV-2 published since January 1, 2020. Each colored data point is a published document. Documents are connected when they use similar words and terminology in their abstracts.

The collection includes daily updates from PubMed, ClinicalTrials.gov, Disaster Lit, and preprints from bioRxiv and medRxiv.

The file contains the details of (and links to) all relevant publications, data sets, and clinical trials relating to COVID-19 research. Dimensions is updated once every 24 hours.

Genetic Engineering & Biotechnology News (GEN) is reporting daily on coronavirus research development

Here you will find expert, curated information for the research and health community on COVID-19. All resources are free to access and include guidelines for clinicians and patients. Under the 'Research' tab, you will find the latest early stage and peer-reviewed research from journals, as well as a link to the Coronavirus hub on ScienceDirect, where you will find every article relevant article to Coronavirus, SARS, and MERS freely available.

Browse the JAMA Network COVID-19 collection, including Q&A's with National Institute of Allergies and Infectious Diseases’ Director, Anthony Fauci, M.D., an interactive map of the outbreak from Johns Hopkins, and past publications on vaccine development, infection control, and public health preparedness.

To assist health workers and researchers working to bring this outbreak to a close, The Lancet has created a Coronavirus Resource Centre. This resource brings together COVID-19 content from across The Lancet journals. All COVID-19 content is free to access.

medRxiv is a free online archive and distribution server for complete but unpublished manuscripts (preprints) in the medical, clinical, and related health sciences.

The public call for rapid sharing of research data relevant to the COVID-19 outbreak is driving an unprecedented surge in (unrefereed) preprints. To help pinpoint the most important research, Nature has launched Outbreak Science Rapid PREreview, with support from Wellcome. This is an open-source platform for rapid review of preprints related to emerging outbreaks.

A collection of articles and other resources on the Coronavirus outbreak, including clinical reports, management guidelines, and commentary. All journal content related to the Covid-19 pandemic is free.

Oxford University Press has made content from online resources and leading journals freely accessible to assist researchers, medical professionals, policy makers, and others who are working to address this health crisis.

This SSRN page provides a curated view into the early-stage research to help researchers, public health authorities, clinicians, and the public.

Research articles from Springer Nature journals, as well as additional commentary and relevant books. All content listed here is free to access.

In addition to the articles related to the current outbreak, Wiley is also making a collection of journal articles and book chapters on coronavirus research freely available to the global scientific community.

COVID-19 resources for front-line clinicians and medical researchers are available in response to the outbreak of coronavirus.

 

Consumer Health Information and Multimedia Resources:

 

Maps and Visuals:

Last Revision